These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 36066745)

  • 21. Psychometric Validation of the Growth Hormone Deficiency-Child Treatment Burden Measure (GHD-CTB) and the Growth Hormone Deficiency-Parent Treatment Burden Measure (GHD-PTB).
    Brod M; Rasmussen MH; Alolga S; Beck JF; Bushnell DM; Lee KW; Maniatis A
    Pharmacoecon Open; 2023 Jan; 7(1):121-138. PubMed ID: 36255609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychometric validation and meaningful change thresholds of the Worst Itching Intensity Numerical Rating Scale for assessing itch in patients with chronic kidney disease-associated pruritus.
    Vernon MK; Swett LL; Speck RM; Munera C; Spencer RH; Wen W; Menzaghi F
    J Patient Rep Outcomes; 2021 Dec; 5(1):134. PubMed ID: 34952964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ileal exclusion for pruritus treatment in children with progressive familial intrahepatic cholestasis and other cholestatic diseases.
    Van Vaisberg V; Tannuri ACA; Lima FR; Tannuri U
    J Pediatr Surg; 2020 Jul; 55(7):1385-1391. PubMed ID: 31708211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis.
    Pepe A; Colucci A; Carucci M; Nazzaro L; Bucci C; Ranucci G; Di Giorgio A; Vajro P; Mandato C
    Front Pediatr; 2023; 11():1061535. PubMed ID: 36865697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Odevixibat: A Novel Bile Salt Inhibitor Treatment for Pruritus in Progressive Familial Intrahepatic Cholestasis.
    Flattmann FE; Mohiuddin FS; Singh A; Tandon A; Lockett SJ; Hirsch JD; Mosieri CN; Kaye AM; Varrassi G; Ahmadzadeh S; Shekoohi S; Kaye AD
    Cureus; 2024 Mar; 16(3):e56886. PubMed ID: 38659510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of Psychometric Properties of the Itch Numeric Rating Scale for Pruritus Associated With Prurigo Nodularis: A Secondary Analysis of a Randomized Clinical Trial.
    Kimel M; Zeidler C; Kwon P; Revicki D; Ständer S
    JAMA Dermatol; 2020 Dec; 156(12):1354-1358. PubMed ID: 32936233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.
    Fokkens W; Trigg A; Lee SE; Chan RH; Diamant Z; Hopkins C; Howarth P; Lund V; Mayer B; Sousa AR; Yancey S; Tabberer M;
    J Patient Rep Outcomes; 2023 Jan; 7(1):4. PubMed ID: 36662344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychometric evaluation of the PROMIS SD-SF-8b instrument in individuals experiencing vasomotor symptoms due to menopause.
    Schultz NM; Morga A; Siddiqui E; Rhoten SE
    Health Qual Life Outcomes; 2023 Nov; 21(1):126. PubMed ID: 37990323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire Short Form (HIS-Q-SF).
    Gelhorn HL; Roberts LJ; Khandelwal N; Revicki DA; DeRogatis LR; Dobs A; Hepp Z; Miller MG
    J Sex Med; 2017 Aug; 14(8):1046-1058. PubMed ID: 28760247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric validation and testing of the 10-item pediatric daily chest-related electronic patient reported outcome (ePRO) diary.
    Arbuckle R; Shea T; Burrows K; Marshall C; Trigg A; Stein J; Albrecht HH
    J Patient Rep Outcomes; 2023 Jan; 7(1):6. PubMed ID: 36695911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring Severity of Respiratory Syncytial Virus (RSV) in Infants and Young Children Using the Pediatric RSV Electronic Severity and Outcome Rating System (PRESORS): Results of Initial Quantitative Validation.
    de la Loge C; Fofana F; Williams P; Rusch S; Stevens M; Scott J
    Patient Relat Outcome Meas; 2021; 12():247-265. PubMed ID: 34326675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychometric Validation and Meaningful Change Thresholds of the New Nasal Polyposis Symptom Diary.
    Shih VH; Slagle AF; Ivanescu C; Flore G; Meyers O; Kreindler J; Martin UJ; Werkström V
    Ann Otol Rhinol Laryngol; 2023 Dec; 132(12):1638-1648. PubMed ID: 37271980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of progressive familial intrahepatic cholestasis on caregivers: caregiver-reported outcomes from the multinational PICTURE study.
    Mighiu C; O'Hara S; Ferri Grazzi E; Murray KF; Schattenberg JM; Ventura E; Karakaidos M; Taylor A; Brrang H; Dhawan A; Willemse J; Finnegan A
    Orphanet J Rare Dis; 2022 Feb; 17(1):32. PubMed ID: 35109890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Qualitative exploration of the visual function impairments and impacts on vision-dependent activities of daily living in Retinitis Pigmentosa and Leber Congenital Amaurosis: content validation of the ViSIO-PRO and ViSIO-ObsRO measures.
    Kay C; Audo I; Naujoks C; Spera C; Fischer MD; Green J; Durham T; Williamson N; Bradley H; Barclay M; Sims J; Banhazi J; Patalano F
    J Patient Rep Outcomes; 2023 Jul; 7(1):74. PubMed ID: 37466759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical outcomes in Alagille syndrome and PFIC: A single institution's 20-year experience.
    Flores CD; Yu YR; Miloh TA; Goss J; Brandt ML
    J Pediatr Surg; 2018 May; 53(5):976-979. PubMed ID: 29729773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing asthma symptoms in children: qualitative research supporting the development of the Pediatric Asthma Diary-Child (PAD-C) and Pediatric Asthma Diary-Observer (PAD-O).
    Bradley H; Trennery C; Jones AM; Lydon A; White F; Williams-Hall R; Arbuckle R; Tomaszewski E; Shih VH; Haughney J; Eisen A; Winders T; Coons SJ; Eremenco S;
    J Patient Rep Outcomes; 2023 Oct; 7(1):104. PubMed ID: 37863864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of the Peak Pruritus Numerical Rating Scale as a Patient-Reported Outcome Measure in Prurigo Nodularis.
    Kwatra SG; Rodriguez D; Dias-Barbosa C; Budhiarso I; Fofana F; Vernon M; Gabriel S; Piketty C; Puelles J
    Dermatol Ther (Heidelb); 2023 Oct; 13(10):2403-2416. PubMed ID: 37615836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and burden of progressive familial intrahepatic cholestasis: a systematic review.
    Jones-Hughes T; Campbell J; Crathorne L
    Orphanet J Rare Dis; 2021 Jun; 16(1):255. PubMed ID: 34082807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a Novel Tool to Assess the Impact of Itching in Pediatric Cholestasis.
    Kamath BM; Abetz-Webb L; Kennedy C; Hepburn B; Gauthier M; Johnson N; Medendorp S; Dorenbaum A; Todorova L; Shneider BL
    Patient; 2018 Feb; 11(1):69-82. PubMed ID: 28710680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of partial internal biliary diversion on long-term outcomes in patients with progressive familial intrahepatic cholestasis: experience in 44 patients.
    Foroutan HR; Bahador A; Ghanim SM; Dehghani SM; Anbardar MH; Fattahi MR; Forooghi M; Azh O; Tadayon A; Sherafat A; Yaghoobi AA; Ashraf MA
    Pediatr Surg Int; 2020 May; 36(5):603-610. PubMed ID: 32206891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.